SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell

Cellular Signalling

Volumn 26, Issue 12, 2014, Pages 2710-2720

  Liu, Hao ^a   Gu, Yixue ^a   Yin, Jiang ^a   Zheng, Guopei ^a   Wang, Chenkun ^a   Zhang, Zhijie ^a   Deng, Min ^a   Liu, Jifang ^a   Jia, Xiaoting ^a   He, Zhimin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; EMT; Lung cancer; NDRG1; SET

Indexed keywords

CISPLATIN; FINGOLIMOD; MYC PROTEIN; N MYC DOWNSTREAM REGULATED GENE1 PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; SET PROTEIN; TRANSCRIPTION FACTOR SNAIL; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CHAPERONE; MYC PROTEIN, HUMAN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SET PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; LUNG TUMOR; METABOLISM; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE CHAPERONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84907609978     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.08.010     Document Type: Article

References (56)

1. Dela Cruz C.S., Tanoue L.T., Matthay R.A. Clin. Chest Med. 2011, 32:605-644.
2. Scagliotti G.V., Novello S., Selvaggi G. Ann. Oncol. 1999, 10(Suppl. 5):S83-S86.
3. Hall M.D., Okabe M., Shen D.W., Liang X.J., Gottesman M.M. Annu. Rev. Pharmacol. Toxicol. 2008, 48:495-535.
4. Holohan C., Van Schaeybroeck S., Longley D.B., Johnston P.G. Nat. Rev. Cancer 2013, 13:714-726.
5. Bedi U., Mishra V.K., Wasilewski D., Scheel C., Johnsen S.A. Oncotarget 2014, 5:2016-2029.
6. Polyak K., Weinberg R.A. Nat. Rev. Cancer 2009, 9:265-273.
7. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Cell 2009, 139:871-890.
8. Rosano L., Cianfrocca R., Spinella F., Di Castro V., Nicotra M.R., Lucidi A., Ferrandina G., Natali P.G., Bagnato A. Clin. Cancer Res. 2011, 17:2350-2360.
9. Singh A., Settleman J. Oncogene 2010, 29:4741-4751.
10. Mochmann L.H., Neumann M., von der Heide E.K., Nowak V., Kuhl A.A., Ortiz-Tanchez J., Bock J., Hofmann W.K., Baldus C.D. Oncotarget 2014, 5:351-362.
11. Chang T.H., Tsai M.F., Su K.Y., Wu S.G., Huang C.P., Yu S.L., Yu Y.L., Lan C.C., Yang C.H., Lin S.B., Wu C.P., Shih J.Y., Yang P.C. Am. J. Respir. Crit. Care Med. 2011, 183:1071-1079.
12. Saxena M., Stephens M.A., Pathak H., Rangarajan A. Cell Death Dis. 2011, 2:e179.
13. Haslehurst A.M., Koti M., Dharsee M., Nuin P., Evans K., Geraci J., Childs T., Chen J., Li J., Weberpals J., Davey S., Squire J., Park P.C., Feilotter H. BMC Cancer 2012, 12:91.
14. Voulgari A., Pintzas A. Biochim. Biophys. Acta 2009, 1796:75-90.
15. Kovacevic Z., Richardson D.R. Carcinogenesis 2006, 27:2355-2366.
16. Sun J., Zhang D., Bae D.H., Sahni S., Jansson P., Zheng Y., Zhao Q., Yue F., Zheng M., Kovacevic Z., Richardson D.R. Carcinogenesis 2013, 34:1943-1954.
17. Melotte V., Qu X., Ongenaert M., van Criekinge W., de Bruine A.P., Baldwin H.S., van Engeland M. FASEB J. 2010, 24:4153-4166.
18. Jang M., Park B., Kang S., Chi S., Cho S., Chung S., Lee S., Bae K., Park S. Oncogene 2009, 28:1529-1536.
19. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T. Nat. Cell Biol. 2004, 6:308-318.
20. Westermarck J., Hahn W.C. Trends Mol. Med. 2008, 14:152-160.
21. Samarin J., Stein I., Horwitz E., Ho C., Chen X., Pikarsky E., Calvisi D., Schirmacher P., Breuhahn K. Z. Gastroenterol. 2014, 52:445.
22. Cohen P., Klumpp S., Schelling D.L. FEBS Lett. 1989, 250:596-600.
23. Switzer C.H., Cheng R.Y., Vitek T.M., Christensen D.J., Wink D.A., Vitek M.P. Oncogene 2011, 30:2504-2513.
24. Saddoughi S.A., Gencer S., Peterson Y.K., Ward K.E., Mukhopadhyay A., Oaks J., Bielawski J., Szulc Z.M., Thomas R.J., Selvam S.P., Senkal C.E., Garrett-Mayer E., De Palma R.M., Fedarovich D., Liu A., Habib A.A., Stahelin R.V., Perrotti D., Ogretmen B. EMBO Mol. Med. 2013, 5:105-121.
25. Cho W.C. Expert Rev. Proteomics 2014, 11:131-133.
26. Liu H., Liu Y.Z., Zhang F., Wang H.S., Zhang G., Zhou B.H., Zuo Y.L., Cai S.H., Bu X.Z., Du J. Mol. BioSyst. 2014, 10:1320-1331.
27. White N.M.A., Masui O., DeSouza L.V., Krakovska O., Metias S., Romaschin A.D., Honey R.J., Stewart R., Pace K., Lee J., Jewett M.A.S., Bjarnason G.A., Siu K.W.M., Yousef G.M. Oncotarget 2014, 5:506-518.
28. Bandyopadhyay S., Pai S.K., Gross S.C., Hirota S., Hosobe S., Miura K., Saito K., Commes T., Hayashi S., Watabe M., Watabe K. Cancer Res. 2003, 63:1731-1736.
29. Bandyopadhyay S., Pai S.K., Hirota S., Hosobe S., Takano Y., Saito K., Piquemal D., Commes T., Watabe M., Gross S.C., Wang Y., Ran S., Watabe K. Oncogene 2004, 23:5675-5681.
30. Alexander S., Friedl P. Trends Mol. Med. 2012, 18:13-26.
31. Chen Z., Zhang D., Yue F., Zheng M., Kovacevic Z., Richardson D.R. J. Biol. Chem. 2012, 287:17016-17028.
32. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. Cell 2008, 133:704-715.
33. Kobayashi A., Okuda H., Xing F., Pandey P.R., Watabe M., Hirota S., Pai S.K., Liu W., Fukuda K., Chambers C., Wilber A., Watabe K. J. Exp. Med. 2011, 208:2641-2655.
34. Wang H., Zhang G., Zhang H., Zhang F., Zhou B., Ning F., Wang H.S., Cai S.H., Du J. Eur. J. Pharmacol. 2014, 723:156-166.
35. Liu W., Xing F., Iiizumi-Gairani M., Okuda H., Watabe M., Pai S.K., Pandey P.R., Hirota S., Kobayashi A., Mo Y.Y., Fukuda K., Li Y., Watabe K. EMBO Mol. Med. 2012, 4:93-108.
36. Li J., Kretzner L. Mol. Cell. Biochem. 2003, 250:91-105.
37. Dang C.V. Cell 2012, 149:22-35.
38. Liu M., Casimiro M.C., Wang C., Shirley L.A., Jiao X., Katiyar S., Ju X., Li Z., Yu Z., Zhou J., Johnson M., Fortina P., Hyslop T., Windle J.J., Pestell R.G. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19035-19039.
39. Bordow S.B., Haber M., Madafiglio J., Cheung B., Marshall G.M., Norris M.D. Cancer Res. 1994, 54:5036-5040.
40. Van Waardenburg R., Prins J., Meijer C., Uges D., De Vries E., Mulder N. Anticancer Res. 1995, 16:1963-1970.
41. Perrotti D., Neviani P. Lancet Oncol. 2013, 14:e229-e238.
42. Von Lindern M., Van Baal S., Wiegant J., Raap A., Hagemeijer A., Grosveld G. Mol. Cell. Biol. 1992, 12:3346-3355.
43. Sun L.X., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H.A. Cancer Cell 2006, 9:287-300.
44. Mukhopadhyay A., Saddoughi S.A., Song P.F., Sultan I., Ponnusamy S., Senkal C.E., Snook C.F., Arnold H.K., Sears R.C., Hannun Y.A., Ogretmen B. FASEB J. 2009, 23:751-763.
45. Ouellet V., Le Page C., Guyot M.C., Lussier C., Tonin P.N., Provencher D.M., Mes-Masson A.M. Int. J. Cancer 2006, 119:2119-2126.
46. Ginos M.A., Page G.P., Michalowicz B.S., Patel K.J., Volker S.E., Pambuccian S.E., Ondrey F.G., Adams G.L., Gaffney P.M. Cancer Res. 2004, 64:55-63.
47. Mukhopadhyay A., Tabanor K., Chaguturu R., Aldrich J.V. Cancer Biol. Ther. 2013, 14:962-972.
48. Farrell A.S., Allen-Petersen B., Daniel C.J., Wang X., Wang Z., Rodriguez S., Impey S., Oddo J., Vitek M.P., Lopez C., Christensen D.J., Sheppard B., Sears R.C. Mol. Cancer Res. 2014, 12:924-939.
49. Neviani P., Santhanam R., Trotta R., Notari M., Blaser B.W., Liu S.J., Mao H., Chang J.S., Galietta A., Uttam A., Roy D.C., Valtieri M., Bruner-Klisovic R., Caligiuri M.A., Bloomfield C.D., Marcucci G., Perrotti D. Cancer Cell 2005, 8:355-368.
50. Christensen D.J., Chen Y., Oddo J., Matta K.M., Neil J., Davis E.D., Volkheimer A.D., Lanasa M.C., Friedman D.R., Goodman B.K., Gockerman J.P., Diehl L.F., de Castro C.M., Moore J.O., Vitek M.P., Weinberg J.B. Blood 2011, 118:4150-4158.
51. Arnold H.K., Sears R.C. Mol. Cell. Biol. 2006, 26:2832-2844.
52. Tan J., Lee P.L., Li Z., Jiang X., Lim Y.C., Hooi S.C., Yu Q. Cancer Cell 2010, 18:459-471.
53. Dent P. Cancer Biol. Ther. 2013, 14:881-882.
54. Farrell A.S., Sears R.C. Cold Spring Harb. Perspect. Med. 2014, 4. (pii: a014365).
55. Neviani P., Harb J.G., Oaks J.J., Santhanam R., Walker C.J., Ellis J.J., Ferenchak G., Dorrance A.M., Paisie C.A., Eiring A.M., Ma Y., Mao H.C., Zhang B., Wunderlich M., May P.C., Sun C., Saddoughi S.A., Bielawski J., Blum W., Klisovic R.B., Solt J.A., Byrd J.C., Volinia S., Cortes J., Huettner C.S., Koschmieder S., Holyoake T.L., Devine S., Caligiuri M.A., Croce C.M., Garzon R., Ogretmen B., Arlinghaus R.B., Chen C.S., Bittman R., Hokland P., Roy D.C., Milojkovic D., Apperley J., Goldman J.M., Reid A., Mulloy J.C., Bhatia R., Marcucci G., Perrotti D. J. Clin. Invest. 2013, 123:4144-4157.
56. Agarwal A., MacKenzie R.J., Pippa R., Eide C.A., Oddo J., Tyner J.W., Sears R.C., Vitek M.P., Odero M.D., Christensen D.J. Clin. Cancer Res. 2014, 20:2092-2103. (clincanres. 2575.2013).